vs
OptimizeRx Corp(OPRX)与万物新生(RERE)财务数据对比。点击上方公司名可切换其他公司
万物新生的季度营收约是OptimizeRx Corp的1.3倍($43.2M vs $32.2M),万物新生净利率更高(16.9% vs 15.6%,领先1.3%)
OptimizeRx Corp是一家总部位于美国的数字健康科技企业,为生命科学公司、医疗机构及药房合作伙伴提供患者参与、药物可负担性和临床沟通相关解决方案,核心产品包括数字购药优惠工具、患者支持项目等,助力提升药物可及性与用药依从性。
万物新生集团(ATRenew Inc.)是中国领先的二手消费电子产品交易与服务平台运营商,核心业务覆盖数码产品回收、质检、翻新及售卖,运营有爱回收等知名品牌,服务覆盖个人消费者及企业客户,市场遍及国内及部分东南亚地区。
OPRX vs RERE — 直观对比
营收规模更大
RERE
是对方的1.3倍
$32.2M
净利率更高
RERE
高出1.3%
15.6%
损益表 — Q4 FY2025 vs Q1 FY2023
| 指标 | ||
|---|---|---|
| 营收 | $32.2M | $43.2M |
| 净利润 | $5.0M | $7.3M |
| 毛利率 | 74.8% | — |
| 营业利润率 | 26.6% | — |
| 净利率 | 15.6% | 16.9% |
| 营收同比 | -0.2% | — |
| 净利润同比 | 6535.9% | — |
| 每股收益(稀释后) | $0.27 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
OPRX
RERE
| Q4 25 | $32.2M | — | ||
| Q3 25 | $26.1M | — | ||
| Q2 25 | $29.2M | — | ||
| Q1 25 | $21.9M | — | ||
| Q4 24 | $32.3M | — | ||
| Q3 24 | $21.3M | — | ||
| Q2 24 | $18.8M | — | ||
| Q1 24 | $19.7M | — |
净利润
OPRX
RERE
| Q4 25 | $5.0M | — | ||
| Q3 25 | $779.0K | — | ||
| Q2 25 | $1.5M | — | ||
| Q1 25 | $-2.2M | — | ||
| Q4 24 | $-78.0K | — | ||
| Q3 24 | $-9.1M | — | ||
| Q2 24 | $-4.0M | — | ||
| Q1 24 | $-6.9M | — |
毛利率
OPRX
RERE
| Q4 25 | 74.8% | — | ||
| Q3 25 | 67.2% | — | ||
| Q2 25 | 63.8% | — | ||
| Q1 25 | 60.9% | — | ||
| Q4 24 | 68.1% | — | ||
| Q3 24 | 63.1% | — | ||
| Q2 24 | 62.2% | — | ||
| Q1 24 | 62.0% | — |
营业利润率
OPRX
RERE
| Q4 25 | 26.6% | — | ||
| Q3 25 | 7.9% | — | ||
| Q2 25 | 10.9% | — | ||
| Q1 25 | -9.6% | — | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | -40.2% | — | ||
| Q2 24 | -19.9% | — | ||
| Q1 24 | -25.5% | — |
净利率
OPRX
RERE
| Q4 25 | 15.6% | — | ||
| Q3 25 | 3.0% | — | ||
| Q2 25 | 5.2% | — | ||
| Q1 25 | -10.0% | — | ||
| Q4 24 | -0.2% | — | ||
| Q3 24 | -42.8% | — | ||
| Q2 24 | -21.3% | — | ||
| Q1 24 | -35.0% | — |
每股收益(稀释后)
OPRX
RERE
| Q4 25 | $0.27 | — | ||
| Q3 25 | $0.04 | — | ||
| Q2 25 | $0.08 | — | ||
| Q1 25 | $-0.12 | — | ||
| Q4 24 | $0.00 | — | ||
| Q3 24 | $-0.50 | — | ||
| Q2 24 | $-0.22 | — | ||
| Q1 24 | $-0.38 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $23.4M | $228.0M |
| 总债务越低越好 | $26.3M | — |
| 股东权益账面价值 | $128.3M | $557.1M |
| 总资产 | $176.9M | $722.9M |
| 负债/权益比越低杠杆越低 | 0.20× | — |
8季度趋势,按日历期对齐
现金及短期投资
OPRX
RERE
| Q4 25 | $23.4M | — | ||
| Q3 25 | $19.5M | — | ||
| Q2 25 | $16.6M | — | ||
| Q1 25 | $16.6M | — | ||
| Q4 24 | $13.4M | — | ||
| Q3 24 | $16.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
总债务
OPRX
RERE
| Q4 25 | $26.3M | — | ||
| Q3 25 | $28.8M | — | ||
| Q2 25 | $29.3M | — | ||
| Q1 25 | $33.8M | — | ||
| Q4 24 | $34.3M | — | ||
| Q3 24 | $36.8M | — | ||
| Q2 24 | $37.3M | — | ||
| Q1 24 | $37.8M | — |
股东权益
OPRX
RERE
| Q4 25 | $128.3M | — | ||
| Q3 25 | $122.3M | — | ||
| Q2 25 | $119.3M | — | ||
| Q1 25 | $116.3M | — | ||
| Q4 24 | $117.0M | — | ||
| Q3 24 | $114.5M | — | ||
| Q2 24 | $121.0M | — | ||
| Q1 24 | $122.5M | — |
总资产
OPRX
RERE
| Q4 25 | $176.9M | — | ||
| Q3 25 | $170.3M | — | ||
| Q2 25 | $169.3M | — | ||
| Q1 25 | $167.8M | — | ||
| Q4 24 | $171.2M | — | ||
| Q3 24 | $165.2M | — | ||
| Q2 24 | $172.9M | — | ||
| Q1 24 | $176.4M | — |
负债/权益比
OPRX
RERE
| Q4 25 | 0.20× | — | ||
| Q3 25 | 0.24× | — | ||
| Q2 25 | 0.25× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.31× | — | ||
| Q1 24 | 0.31× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $7.1M | — |
| 自由现金流经营现金流 - 资本支出 | $7.1M | — |
| 自由现金流率自由现金流/营收 | 22.0% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 1.41× | — |
| 过去12个月自由现金流最近4个季度 | $18.7M | — |
8季度趋势,按日历期对齐
经营现金流
OPRX
RERE
| Q4 25 | $7.1M | — | ||
| Q3 25 | $3.2M | — | ||
| Q2 25 | $4.6M | — | ||
| Q1 25 | $3.9M | — | ||
| Q4 24 | $198.0K | — | ||
| Q3 24 | $1.8M | — | ||
| Q2 24 | $782.0K | — | ||
| Q1 24 | $2.1M | — |
自由现金流
OPRX
RERE
| Q4 25 | $7.1M | — | ||
| Q3 25 | $3.2M | — | ||
| Q2 25 | $4.6M | — | ||
| Q1 25 | $3.8M | — | ||
| Q4 24 | $181.0K | — | ||
| Q3 24 | $1.8M | — | ||
| Q2 24 | $737.0K | — | ||
| Q1 24 | $2.1M | — |
自由现金流率
OPRX
RERE
| Q4 25 | 22.0% | — | ||
| Q3 25 | 12.2% | — | ||
| Q2 25 | 15.6% | — | ||
| Q1 25 | 17.5% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 8.3% | — | ||
| Q2 24 | 3.9% | — | ||
| Q1 24 | 10.6% | — |
资本支出强度
OPRX
RERE
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.2% | — |
现金转化率
OPRX
RERE
| Q4 25 | 1.41× | — | ||
| Q3 25 | 4.11× | — | ||
| Q2 25 | 2.98× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图